Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003

Pediatric Infectious Disease Journal

Volumn 27, Issue 10, 2008, Pages 907-912

  Feja, Kristina ^a,b   McNelley, Erin ^c   Tran, Cindy S ^d   Burzynski, Joseph ^e   Saiman, Lisa ^f  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Latent TB infection; Multidrug resistance; New York City; Pediatrics; Tuberculosis

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; BLURRED VISION; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DRUG WITHDRAWAL; FEMALE; HEARING LOSS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TREATMENT DURATION; UNITED STATES; ADOLESCENT; DIRECTLY OBSERVED THERAPY; INFANT; NEWBORN; PRESCHOOL CHILD; TREATMENT OUTCOME; TUBERCULOSIS;

ADOLESCENT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DIRECTLY OBSERVED THERAPY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEW YORK CITY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 54049103333     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181783aca     Document Type: Article

References (38)

1. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug- resistant tuberculosis in the United States. JAMA. 1994;271:665-671.
2. Tuberculosis in New York City, 2003: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 2004.
3. Freiden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med. 1995;333:229-233.
4. Bureau of Tuberculosis Control New York City Department of Health. Clinical Policies and Protocols. 3rd ed. New York, NY: New York City Department of Health; 1999.
5. Steiner P, Rao M. Drug-resistant tuberculosis in children. Semin Pediatr Infect Dis. 1993;4:275-282.
6. Schluger NW, Lawrence RM, McGuiness G, Park M, Rom WN. Multidrug-resistant tuberculosis in children: two cases and a review of the literature. Pediatr Pulmonol. 1996;21:138-142.
7. Schaaf HS, Gie RP, Kennedy M, et al. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30- month follow-up. Pediatrics. 2002;109:765-771.
8. Schaaf HS, Shean K, Donald PR. Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome. Arch Dis Child. 2003;88:1106-1111.
9. Mukherjee JS, Joseph JK, Rich ML, et al. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. Int J Tuberc Lung Dis. 2003;7:637-644.
10. Soeters M, de Vries AM, Kimpen JL, et al. Clinical features and outcome in children admitted to a TB hospital in the Western Cape-the influence of HIV infection and drug resistance. S Afr Med J. 2005;95: 602-606.
11. Drobac PC, Mukherjee JS, Joseph JK, et al. Community-based therapy for children with multidrug-resistant tuberculosis. Pediatrics. 2006;117:2022-2029.
12. Padayatchi N, Bamber S, Dawood H, Bobat R. Multidrug-resistant tuberculous meningitis in children in Durbin, South Africa. Pediatr Infect Dis J. 2006;25:147-150.
13. San Gabriel P, Saiman L, Kaye K, Silin M, Onorato I, Schulte J. Completeness of pediatric TB reporting in New York City. Public Health Rep. 2003;118:144-153.
14. TB Annual Summary: 2006. New York, NY: New York City Department of Health and Mental Hygiene; 2008.
15. Tuberculosis in New York City, 1995: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 1996.
16. Tuberculosis in New York City, 1996: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 1997.
17. Tuberculosis in New York City, 1997: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 1998.
18. Tuberculosis in New York City, 1998: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 1999.
19. Tuberculosis in New York City, 1999: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 2000.
20. Tuberculosis in New York City, 2000: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 2001.
21. Tuberculosis in New York City, 2001: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 2002.
22. Tuberculosis in New York City, 2002: Information Summary. New York, NY: New York City Department of Health and Mental Hygiene; 2003.
23. Munsiff S, Bassoff T, Nivin B, et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis. 2002;8:1230-1238.
24. Granich RM, Oh P, Lewis B, Porco TC, Flood J. Multidrug resistance among persons with tuberculosis in California, 1994-2003. JAMA. 2005;293:2732-2739.
25. Nelson LJ, Schneider E, Wells CD, Moore M. Epidemiology of childhood tuberculosis in the United States from 1993-2001: the need for continued vigilance. Pediatrics. 2004;114:333-341.
26. Steiner P, Rao M, Victoria MS, Hunt J, Steiner M. A continuing study of primary drug-resistant tuberculosis among children observed at the Kings County Hospital Medical Center between the years 1961-1980. Am Rev Respir Dis. 1983;128:425-428.
27. World Health Organization. Antituberculosis Drug Resistance in the World, Report No. 3. 2004.
28. Starke JR, Jacobs RF, Jereb J. Resurgence of tuberculosis in children. J Pediatr. 1992;120:839-855.
29. Smith KC, Seaworth BJ. Drug-resistant tuberculosis: controversies and challenges in pediatrics. Expert Rev Anti Infect Ther. 2005;3:995-1010.
30. Swanson DS, Starke JR. Drug-resistant tuberculosis in pediatrics. Pedi- atr Clin North Am. 1995;42:553-581.
31. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993;328:527-532.
32. Mitnick CD, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med. 2003;348: 119-128.
33. Fischl MA, Daikos GL, Uttamchandani RB, et al. Clinical presentation and outcome of patients with pulmonary tuberculosis caused by multiple-drug resistant bacilli. Ann Intern Med. 1992;117:184-190.
34. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 2004;169:1103-1109.
35. Tahaoglu K, Torun T, Sevim T, et al. The treatment of multidrug-resistant tuberculosis in Turkey. N Engl J Med. 2001;345:170 -174.
36. Grady R. Safety profile of quinolone antibiotics in the pediatric population. Pediatr Infect Dis J. 2003;22:1128-1132.
37. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J. 1997;16:127-129; discussion 160-162.
38. Chalumeau M, Tonnelier S, D'Athis P. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics. 2003;111(6 Pt 1):e714-e719.